Ichiro Nakachi

4.0k total citations
34 papers, 629 citations indexed

About

Ichiro Nakachi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ichiro Nakachi has authored 34 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Ichiro Nakachi's work include Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ichiro Nakachi is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ichiro Nakachi collaborates with scholars based in Japan, United States and Brazil. Ichiro Nakachi's co-authors include Kenzo Soejima, Katsuhiko Naoki, Ichiro Kawada, Hideo Watanabe, Akitoshi Ishizaka, Satoshi Yoda, Hiroyuki Yasuda, Hiroyuki Yasuda, Wilbur A. Franklin and Moumita Ghosh and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

Ichiro Nakachi

33 papers receiving 623 citations

Peers

Ichiro Nakachi
Ichiro Nakachi
Citations per year, relative to Ichiro Nakachi Ichiro Nakachi (= 1×) peers Jan Nyrop Jakobsen

Countries citing papers authored by Ichiro Nakachi

Since Specialization
Citations

This map shows the geographic impact of Ichiro Nakachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Nakachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Nakachi more than expected).

Fields of papers citing papers by Ichiro Nakachi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Nakachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Nakachi. The network helps show where Ichiro Nakachi may publish in the future.

Co-authorship network of co-authors of Ichiro Nakachi

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Nakachi. A scholar is included among the top collaborators of Ichiro Nakachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Nakachi. Ichiro Nakachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoh, Kiyotaka, Yoshitaka Zenke, Shingo Kitagawa, et al.. (2023). 1276P Genomic screening by multi-gene assay for perioperative targeted therapy in patients with early-stage non-small cell lung cancer: LC-SCRUM-Advantage/MRD. Annals of Oncology. 34. S737–S737. 1 indexed citations
2.
Zenke, Yoshitaka, Kiyotaka Yoh, Shingo Kitagawa, et al.. (2023). 1282P Concordance of PD-L1 expression between biopsy and matched surgical specimen in early-stage non-small cell lung cancer: LC-SCRUM-Advantage/MRD. Annals of Oncology. 34. S740–S741. 1 indexed citations
3.
Watanabe, Satoshi, Naoki Furuya, Atsushi Nakamura, et al.. (2023). A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study). European Journal of Cancer. 197. 113469–113469. 8 indexed citations
5.
Ghosh, Moumita, et al.. (2022). Lung cancer: Premalignant biology and medical prevention. Seminars in Oncology. 49(3-4). 254–260. 4 indexed citations
6.
Tani, Tetsuo, Ichiro Nakachi, Shinnosuke Ikemura, et al.. (2021). Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer. Cancer Management and Research. Volume 13. 7497–7503. 6 indexed citations
7.
Baba, Rie, Ichiro Nakachi, Katsunori Masaki, et al.. (2020). Repetitive instructions at short intervals contribute to the improvement of inhalation technique. Asia Pacific Allergy. 10(2). e19–e19. 5 indexed citations
8.
Maemondo, Makoto, Tatsuro Fukuhara, Haruhiro Saito, et al.. (2020). NEJ026: Final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations.. Journal of Clinical Oncology. 38(15_suppl). 9506–9506. 42 indexed citations
9.
Kobayashi, Keigo, Ichiro Nakachi, Daisuke Arai, et al.. (2019). Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report. Clinical Lung Cancer. 21(1). e30–e32. 5 indexed citations
10.
Kobayashi, Keigo, Ichiro Nakachi, Katsuhiko Naoki, et al.. (2018). Real-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter Analysis. Clinical Lung Cancer. 19(3). e349–e358. 45 indexed citations
11.
Ghosh, Moumita, York E. Miller, Ichiro Nakachi, et al.. (2017). Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 197(7). 885–896. 80 indexed citations
12.
Irie, H., Shotaro Chubachi, Minako Sato, et al.. (2017). Characteristics of patients with increasing COPD assessment test scores within 3 years. Respiratory Medicine. 131. 101–108. 7 indexed citations
13.
Paskulin, Diego D’Ávila, Juliana Giacomazzi, Ichiro Nakachi, Marileila Varella‐Garcia, & Patrícia Ashton‐Prolla. (2014). High-density SNP array analysis of TP53 p.R337H mutation carriers.. Journal of Clinical Oncology. 32(15_suppl). e12500–e12500. 1 indexed citations
14.
Nakachi, Ichiro, Jessica L. Rice, Christopher D. Coldren, et al.. (2013). Application of SNP Microarrays to the Genome-Wide Analysis of Chromosomal Instability in Premalignant Airway Lesions. Cancer Prevention Research. 7(2). 255–265. 18 indexed citations
15.
Hoffman, Lindsey M., Andrew M. Donson, Ichiro Nakachi, et al.. (2013). Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma. Acta Neuropathologica. 127(5). 731–745. 57 indexed citations
16.
Naoki, Katsuhiko, Kenzo Soejima, Hiroaki Okamoto, et al.. (2011). The PCR-invader method (structure-specific 5′ nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing. International Journal of Clinical Oncology. 16(4). 335–344. 39 indexed citations
17.
Yasuda, Hiroyuki, Kenzo Soejima, Sohei Nakayama, et al.. (2010). Bronchoscopic Microsampling is a Useful Complementary Diagnostic Tool for Detecting Lung Cancer. Lung Cancer. 72(1). 32–38. 17 indexed citations
18.
Yoda, Satoshi, Kenzo Soejima, Hiroyuki Yasuda, et al.. (2010). A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients. Cancer Chemotherapy and Pharmacology. 67(3). 717–722. 4 indexed citations
19.
Kawada, Ichiro, Kenzo Soejima, Hideo Watanabe, et al.. (2008). An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients. Journal of Thoracic Oncology. 3(10). 1096–1103. 34 indexed citations
20.
Watanabe, Hideo, Kenzo Soejima, Hiroyuki Yasuda, et al.. (2008). Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell International. 8(1). 15–15. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026